share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

SEC announcement ·  Jun 10 21:33
Summary by Futu AI
Novo Nordisk A/S, a leading global healthcare company, has announced the continuation of its share repurchase program, which began on February 6, 2024. As part of a 12-month plan to buy back shares worth up to DKK 20 billion, the company initiated a specific repurchase phase on May 6, 2024, with the intention to acquire B shares for up to DKK 2.2 billion between May 7, 2024, and August 5, 2024. Since the last update on June 3, 2024, Novo Nordisk has purchased an additional 154,000 B shares at an average price of DKK 950.28, amounting to a total transaction value of DKK 146,319,451. This brings the accumulated repurchases under the current program to 786,545 B shares, totaling DKK 724,234,837. As of June 7, 2024, the company has acquired 9,520,795 B shares at an average price of DKK 866.73 since the beginning of the repurchase plan, representing a total spend of DKK 8,251,969,609. Novo Nordisk now holds 10,886,359 B shares as treasury shares, which is 0.2% of the share capital. The company's shares are traded on Nasdaq Copenhagen and the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has announced the continuation of its share repurchase program, which began on February 6, 2024. As part of a 12-month plan to buy back shares worth up to DKK 20 billion, the company initiated a specific repurchase phase on May 6, 2024, with the intention to acquire B shares for up to DKK 2.2 billion between May 7, 2024, and August 5, 2024. Since the last update on June 3, 2024, Novo Nordisk has purchased an additional 154,000 B shares at an average price of DKK 950.28, amounting to a total transaction value of DKK 146,319,451. This brings the accumulated repurchases under the current program to 786,545 B shares, totaling DKK 724,234,837. As of June 7, 2024, the company has acquired 9,520,795 B shares at an average price of DKK 866.73 since the beginning of the repurchase plan, representing a total spend of DKK 8,251,969,609. Novo Nordisk now holds 10,886,359 B shares as treasury shares, which is 0.2% of the share capital. The company's shares are traded on Nasdaq Copenhagen and the New York Stock Exchange.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.